Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Real World Study Of Upadacitinib in Ulcerative Colitis (PROFUNDUS)

NCT05494606 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05494606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05494606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Real World Study Of Upadacitinib in Ulcerative Colitis (PROFUNDUS)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
August 15, 2022
Completion date
March 31, 2028
Enrollment
785 (actual)
Sites
153

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis